Additional file 3 of Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial
收藏DataCite Commons2022-01-06 更新2024-07-29 收录
下载链接：
https://springernature.figshare.com/articles/dataset/Additional_file_3_of_Hepatocellular_carcinoma_patients_with_high_circulating_cytotoxic_T_cells_and_intra-tumoral_immune_signature_benefit_from_pembrolizumab_results_from_a_single-arm_phase_2_trial/17913051/1
下载链接
链接失效反馈官方服务：
资源简介：
Additional file 3: Table S1. Clinicopathological information for pembrolizumab-treated HCC patients.
提供机构：
figshare
创建时间：
2022-01-06
